Sheela Foam Limited (SFL) Earnings Call Transcript
November 3, 2026
Earnings Call Speaker Segments
Ladies and gentlemen, good day, and welcome to the Sheela Foam Limited Q2 H1 FY '27 Earnings Conference Call, hosted by Emkay Global Financial Services Limited. <<operator_script>> Please be aware that this conference is being recorded. I now hand the conference over to Mr. Devanshu Bansal from Emkay Global Financial Services Limited. Thank you, and over to you, Mr. Bansal.
Yes. Good afternoon, everybody. I want to welcome the management team and express our appreciation for this chance. Joining us on the call today are Rahul Gautam, Chairman and Managing Director; Tushaar Gautam, Vice Chairman and Joint Managing Director; Rakesh Chahar, Deputy Managing Director; and Amit Kumar Gupta, Group Chief Financial Officer. At this point I will turn the call over to the management for their opening remarks. Gentlemen, over to you.
Thank you, Devanshu. I need to make one small correction — Tushaar Gautam isn't available right now. Good afternoon, ladies and gentlemen, and thanks for being with us to go over our results for the second quarter, Q2, and the first half, H1, of this year. I hope you've had an opportunity to review the numbers and the presentations. Let me start with the environment. As it has already really shaped this quarter. Starting in February, this has been a truly unprecedented period for our industry. Roughly speaking, crude is up by about 50%, and our 2 key raw materials have risen even more. Since mid-February, polyol — our main chemical, or main raw material — is up by 65%, and TDI by 33%. Increases of this magnitude, sustained like this, have simply never been seen before. The war has disrupted the whole supply chain and logistics. A few facilities in the Middle East have been partially destroyed, and others are constrained due to the Hormuz blockage. On top of that, the festive season, which fell in late September last year, shifted into October this time, which moved demand from Q2 into Q3.
But we do understand that these are times when a leader's strength becomes evident. When conditions become this difficult, our primary duty is to continue serving our customers, and that is exactly what we did. At a moment when many of the smaller unorganized players simply could not source or hold their prices, we kept material flowing through supplier relationships that have been built over decades. With the strength of the brands, we've had the advantage of being able to pass these increases on to the market and eventually to the consumer. The consumer has his own affordability benchmarks also. A customer who comes in with about INR 20,000 to spend on a mattress can stretch a bit, but not to the full impact of the large price increase. The same money now buys him a slightly lower category of the product, and that change impacts us even when values may hold up. With demand still soft, we have chosen to spend more and not less on our brands, advertising and consumer schemes. We went out and launched the Great Sleepwell Festival across the country. It has turned out one of the strongest schemes we have ever introduced for our consumers.
Sure, this does shave off some profitability near term, yet it has generated a solid demand pipeline as we head into the festive quarters of the second half. What that means is that despite a margin hit, we've kept profitability steady in absolute terms. During a quarter such as this one, safeguarding the business's core while continuing to invest in it mattered to us. The figures make that plain. Consolidated revenue rose roughly 19% in the quarter, reaching INR 1,045 crores. That marks the first time we've surpassed the INR 1,000 crore revenue figure in Q2, and it's also our third straight quarter of growth above 15%. Operating EBITDA came in at INR 87 crores for the quarter, essentially matching what we posted in the same quarter last year. PAT was INR 46 crores, roughly 5x last year's figure. Turning to the half year, revenue climbed about 22% to INR 2,076 crores -- INR 2,077 crores, while operating EBITDA rose 23% to the INR 200 crore mark from INR 162 crores a year earlier, at a 9.6% margin. I should also mention that PAT increased to INR 109 crores, which is over 6x last year.
Even though our gross margins came in above where they were in Q1 of this year, the money we put into brand and marketing meant our operating EBITDA margins stayed flat. I'd like to take a moment now to talk about Furlenco, since I think it truly reshapes how you should see our group. As of 1st October — 1st October of this year — Furlenco is now a subsidiary of Sheela Foam. This isn't something that happened overnight. We've been working toward it for a while, and it extends our reach, our scale, and the very character of what we do. Let me walk you through the business, because it's quite different from what we already have. Furlenco is mainly in furniture rental. It provides city dwellers with access to well-designed furniture, on a subscription basis, with no need to own any of it — or all of it. We used to think nobody would want to rent these things. That's the view we'd always held. But these days it isn't just the floating population — it's people who simply enjoy a change, who like their furniture maintained in good condition, who relocate to new homes or new cities, and they're all embracing this offering. Furlenco gives them a catalog of over 300 products. It operates in over 30 cities.
Its subscriber count exceeds 200,000 — or 2 lakh — and the company operates a disciplined asset-based model in which asset utilization stays well above 90%. That discipline is precisely what makes the business profitable. What this company has achieved in such a short span reveals a lot about our capacity to identify value and then build on it. At the time of our investment in FY '24, Furlenco's revenue stood at roughly INR 139 crores, with a subscriber base of 70,000. On top of that, it was losing approximately INR 130 crores annually. Following the turnaround, we expect it to close this year at the INR 500 crore mark, with an EBITDA margin of roughly 40% — going from deep losses to a profitable business whose revenue is nearly 4x what it was in about 3 years, and it is still growing at over 30%. That is where Furlenco stands today. The first half of the year shows the same recent trend for Furlenco. Revenue rose about 34% — to 34%, reaching INR 229 crores — and EBITDA also climbed by roughly 69%, hitting a level of INR 89 crores. Its attractive subscriber base has expanded 35% compared with the prior year. This is a space whose time has come.
Furniture rental is gaining genuine traction, especially among younger and Gen Z buyers, who prize flexibility much more highly than ownership. The capital markets have noticed too, since one company operating in this segment went public not long ago. All of this has reshaped what Sheela Foam is as a group today. We've strengthened our B2C portfolio across numerous growth areas — a house of over 13 brands united by a single idea that has steered us since the very start: the science of comfort for every consumer we serve. The group now rests on primarily 4 pillars. The first is mattresses, where we cater to every type of customer, from mass to premium to luxury. Sleepwell and Kurlon occupy the premium and economy ends. Tarang and Aram provide depth and reach across the value segments, while Chattam & Wells and Nature's Rest carry us into luxury. Furniture, in both rental and retail, forms the second pillar, led by Furlenco and complemented by our move into branded furniture retail under the flagship Sleepwell and Kurlon brands. Foam and cushioning is the third category, or third pillar. Our technical and industrial foam business within B2B, as well as B2C through brands like FerroFoam and <<inaudible>>, among others, performs well in this space.
This serves not just consumers but a far broader range of industries, with uses stretching from automotive through to footwear, and across every one of those our foam has been a benchmark for a long time. And the fourth piece is the international subsidiaries along with the IT initiative that we have. Our operations overseas — Joyce in Australia, Interplasp in Spain, and our enterprise technology and digital solutions company, Staqo — have each performed extremely well. Sheela Foam today is a broad-based consumer company, with brands at home and abroad spanning categories, channels, price points and markets. With these pieces coming together, we expect the combined group to finish this year at revenue of around INR 5,000 crores, with EBITDA of roughly INR 600 crores — a margin a little above 12%. I should also mention that the international businesses stay strong and profitable. In Spain, revenue grew well. We brought on new customers during the quarter, and their volumes will start to show from the second half. The cost of winning and servicing did weigh on Spain's margin this quarter, but in my view that is money well spent for the growth ahead. For the half, Spain has already delivered an EBITDA margin of over 10% — 10.7%, to be exact.
In Australia, Joyce performed well — the business was well run and did well at the operating level, with an EBITDA margin also of 10.7% in the quarter and 13.4% for the half year. The profit we reported for the quarter got pulled down by a one-off provision we had to take against one of our key customers, A.H. Beard, going into administration. We expect to normalize this very soon. Our newer growth engines also continue to perform well. On the D2C and e-commerce side, we are strong and keep growing at a healthy pace, led by our own website, brand.com. The U2O business — that is the unorganized to organized business, which takes us from the unorganized to the organized market — has now reached more than 10,000 touch points or dealers and has grown by about 41%. And Staqo, as I mentioned, our technology company, keeps growing well, while holding a healthy EBITDA margins of around 28%. Let me close here. This was a quarter that tested us on every front, and I believe we managed to handle it reasonably well by standing with our customers, investing through the cycle and holding the profitability of the business to the previous levels. With Furlenco now part of the family, the portfolio is wide, is actually very bright.
I have no doubt that Sheela Foam will keep moving along its growth path from here. So with that, I'll hand things over to our Group CFO, Mr. Amit Kumar Gupta, who will walk us through the financials in greater detail. Thank you so much.
Thank you, sir. Ladies and gentlemen, allow me now to walk you through the financial results for the quarter and for the first half of this financial year. Consolidated revenue from operations rose to INR 1,045 crores, up 19% versus the comparable quarter a year earlier, supported by growth in mattresses as well as foam and by very strong growth in Australia and Spain. Operating EBITDA for the quarter came in at INR 87 crores, an 8.4% margin, essentially unchanged from INR 87 crores a year ago. Reported EBITDA stood at INR 83 crores. As Rahul sir explained, the pressure came from the steep increase in polyol and TDI prices and from the higher spend behind the Great Sleepwell festival. PAT for the quarter reached INR 46 crores versus INR 10 crores last year, close to 5x, aided both by operations and by lower finance cost and depreciation. Cash EPS for the quarter was INR 8.3. For the half year, consolidated revenue increased 22% to INR 2,077 crores from INR 1,696 crores. Operating EBITDA rose roughly 23% to INR 200 crores from INR 162 crores, at a margin of 9.6%. The operating leverage of the first quarter was partly offset by raw material inflation in the second -- sorry, PAT for the second half climbed to -- PAT for the first half climbed to INR 109 crores from INR 17 crores last year for the similar period, and EPS rose to INR 18.7 from a diluted EPS of around INR 9.8 last year.
Taking it on a stand-alone basis, quarterly revenue rose 17% to INR 781 crores, while EBITDA came in at INR 61 crores, a margin of 7.8%. Stand-alone revenue for H1 this year was up 18% at INR 1,452 crores, and EBITDA increased 5% to INR 129 crores. Looking at segments for the first half, Mattress was up 11% and Foam up 26%, with volumes roughly flat, which reflects the pricing actions and the shift in the festive season. Turning to the business abroad, Australia and Joyce posted half year revenue of -- in Australia, Joyce recorded half year revenue of INR 241 crores, up 16% year-on-year, with an operating EBITDA margin of about 13.4%. In Spain, Interplasp's half year revenue was INR 250 crores, a growth of 44%, with an EBITDA margin of 10.7%. Furlenco, which became our subsidiary from 1st October, had revenue of roughly INR 229 crores, EBITDA of INR 89 crores and a margin near 39%. Starting in the third quarter, our consolidated revenue numbers will also reflect Furlenco as a subsidiary. With that, I'd ask the moderator to open the floor for questions. Thank you.
<<operator_script>> Our initial question is from Harshit Khadka of RoboCapital.
So across the last 2 quarters, other income came to INR 22 crores, right? Could you break that other income down for us? And what type of other income should we expect in H2 FY '27?
Other income covers all income not tied directly to operations. We hold an investment of roughly INR 110 crores. So a return of about 10% to 12% per annum forms part of that. If any asset sales happen during the quarter, any gain or loss arising from any revaluation, et cetera, all of those fall under other income. They can't be counted in operating income. Historically, we've observed that other income stays in the range of INR 10 crores per quarter. And looking ahead, we expect it to be in a similar range.
Okay, sir. Understood. And sir, during the opening commentary, you said you would achieve INR 5,000 crores of top line along with INR 600 crores of EBITDA. So what time line was that for?
Let's start by clarifying where that INR 5,000 crores figure is coming from. As things stand today, in the current year we expect Sheela Foam consolidated to do roughly INR 4,300 crores to INR 4,400 crores. Furlenco is anticipated to do about INR 500 crores to INR 600 crores this year. Combined, those get us to INR 5,000 crores. On the EBITDA side, if you look, last year we did around INR 400-odd crores. This time, perhaps we'll do INR 50 crores to INR 100 crores more than that. Furlenco will contribute INR 200 crores. Adding it up gives a number of INR 600-plus crores. So that's what we meant when we said the current run rate will be post Furlenco consolidation.
Okay, got it. And sir, at Sheela Foam we're running EBITDA margins of about 11%. So is it possible we'll see those margins tick up — say to 12% or 13% — over the next 2, 3 quarters?
Right, so that’s what had been expected. But at the moment, given how raw material prices have risen and how large that increase has been, I think we made a bit of a trade-off between business volume and the profitability we could extract from it. Our focus was essentially on the absolute profitability achievable. As a result, margins have been somewhat compromised, while in absolute terms profitability has been preserved. My hope is that if the Middle East situation settles and we see at least some degree of normalization in raw material prices, we would see EBITDA at a double-digit level. Right now it is not double digit. At the consolidated level, it is 9% to 10%. And if things return to a situation like the one before February, I think roughly 12% would be a sensible profitability level for us to expect, and that is without Furlenco. If you add Furlenco, it would be 3 percentage points higher.
Up next, we have a question from Ravi Purohit, who is with Securities Investment Management Private Limited.
Sir, I have a couple of questions. First, how does this consolidation with Furlenco take place? What stake do we currently hold in that company? And I believe there are also some convertibles still outstanding in that company, correct? So could you help us grasp the bigger picture of how this consolidation comes about?
Regarding Furlenco, our holding stands at roughly 43% on a diluted basis. Some private equity investors are also involved there. But during the current quarter they relinquished their special rights, and that hands us absolute control of the company, which by itself entitles us to consolidate it or treat it as our subsidiary. So this took effect from 1st of October onwards. You'll therefore see the consolidation in the third quarter. It will be line-by-line consolidation for both the P&L and the balance sheet. And in the P&L, minority interest gets reduced at the bottom. So both top line and EBITDA will be added. On CCPS, generally in start-ups, equities get issued in the form of CCPS. So there are many CCP issued earlier, maybe 5 years, 7 years back, and to some extent to us as well, the equity was issued in the form of CCPS, but they are convertible into equity shares at any time at our discretion. So whenever we look at our stake, we look on a fully diluted basis, and that is 43% currently.
All right. But the way things stand right now — right now — we hold 35%. So the consolidation figures are going to be split proportionally at 35% and 65%, correct? That only changes once those get converted, will.
Let me walk through that. From an accounting standpoint, consolidation happens solely according to the percentage of converted equity shares you hold. As I said, we hold some CCPS, and other investors hold some CCPS as well. So as things currently stand for accounting purposes, we consolidate just 35%. That is what the standards <<inaudible>>. In reality, though, our stake comes to 43% on a fully diluted basis. Looking ahead, yes, there will be 100% consolidation on a line-by-line basis.
Alright. And then, underneath that line, essentially the minority interest that’s left will be subtracted, right?
Yeah, yeah.
Alright. Alright. And sir, my second question concerns the expenses, which have risen. I believe our MD mentioned that we had kind of gone ahead and spent money on market building and ad spend and promotions given the run-up to the festive season. But if you could just share some insights on what are the areas where we've kind of spent these. And also, I see a significant bump up in the employee expenses. So if you could just kind of share some thoughts on the significant -- because at the gross margin level, the gross margins have actually been held up quite well. So RM impacts the gross margin. But in this quarter, they don't seem to have been impacted that much. So the impact on the EBITDA margin is actually between gross profit and the -- between employee expense and other expense. So if you could just spend some time helping us understand the movement in employee expenses as well as the other expenses, that will be helpful.
Yes. So I'll start with the other expenses. Across the 4 quarters of a year, the amount we invest in advertising varies. It peaked during the festive season. As a result, in the third quarter you'll observe the largest marketing or advertising spend, and that pattern has held in earlier years too. The second quarter comes in above the first quarter. So we had planned a certain level of marketing expenditure. But given the current situation, we feel it would pay off to put some money into marketing and carve out a niche for ourselves. So we ended up spending roughly INR 15 crores to INR 16 crores more on advertising this quarter than what we had anticipated. On other expenses, compared with the same quarter a year ago, we're up by about INR 8 crores. And compared with the first quarter, we're up by INR 15 crores. So that gap is essentially driven by advertising cost. Turning to manpower, it has 2 components. First, about INR 8 crores comes from Australia and Spain being converted into Indian rupees.
And what you'd notice is that after the Indian rupee depreciated against the euro and the Australian dollar, both the top line and the cost lines moved higher. So roughly INR 8 crore of the impact comes from converting euros and Australian dollars into Indian rupees. That isn't a real increase in expense. And about 8% to — 8%, 9% would be the effect of the annual increments. No other incremental manpower cost is rising. So effectively, what you're seeing here, INR 112 crores to INR 132 crores — INR 122 crores, INR 8 crores is just the foreign exchange difference, and expenses rose by only INR 12 crores.
Also, we referred to certain provisions at one of our overseas subsidiaries. What do those provisions pertain to?
Right. So one customer of ours in Australia that we've talked about, A. H. Beard, went bankrupt — entered administration roughly 6 months ago. The administrator has made a decision on that administration, and we were forced to accept a haircut of about 38% on what was outstanding from them, which came to roughly INR 7 crores in Indian rupees. So those INR 7 crores had to be provided for between the first and second quarters.
All right, all right. So at this point, once you make the adjustment for this INR 83 crores and INR 87 crores, basically what's left as the difference is this number.
Could you say that again, please?
When you look at operating EBITDA — the figures we show in the presentation are INR 83 crores and INR 87 crores — so on a normalized basis it comes to INR 87 crores, while the reported figure stands at INR 83 crores. That INR 4 crores gap is exactly what separates the two, correct?
Right, since this is a one-time cost and won't come up again next quarter, we provided both figures so you can get a sense of what a sustainable profitability level looks like for the company.
Okay, on that final question, I think over the past 1 year we've consistently said we're aiming to reach 13%, 14% EBITDA margins, right, perhaps by next year. So does that seem realistic? In fact, on one con call, I believe we even mentioned that we're looking at 14% to 15% EBITDA margins as well, right? So if things settle down today, does that look like a reasonable number for us to target? Or do you think we'll need to keep spending on ad spend and marketing, and it seems -- so if you could share some medium-term thoughts on how we should view our margin path?
Okay, so let’s break down the P&L a bit. As you can see, my gross margins right now sit at about 38%, correct? In the past, they’ve ranged from 40% to 42%. The reason that gap still exists is that with certain institutional customers — particularly automotive and others, and also in the Mattress segment — you’re able to raise prices only up to a certain point. So we began lifting prices once we hit that certain level. And now that they’ve gone up, we’re still covering raw material costs, but restoring margins becomes somewhat difficult. Since this is a temporary situation, we also consider it from the standpoint of keeping our customers stable. So once — I believe once this has eased or normalization arrives, whether in oil prices or logistics costs around the world, and goods begin flowing freely again, we ought to at least get those margins back. So even if you add 2% to 3% to the margins we have now, you’ll find we’re right where we said we’d be before the war started or last year — the margins we stated. For next year’s margins, as you mentioned, we had said yes, we will achieve between 13% and 15%.
In a completely normal situation, yes, we definitely would have done that—we were on track for it. Now it hinges on how long the current situation persists. If it keeps going the way it is, I think reaching it will be difficult. But should things return to normal, we'll try to get there. We will certainly make every effort to achieve it.
<<operator_script>> Our following question is from Ritesh Shah with Investec India.
I've got a few questions. First, sir, how should we think about the gross margin holding up on a sequential basis? That's my first question. I think you mentioned price elasticity somewhat, where we recovered the raw material increases — which, if I can infer, basically means we try to pass through everything on the raw material side. But you did suggest that recovering margins is a challenge. So how are we viewing this, gross versus EBITDA, or volume versus profitability? That's the first question.
Okay Ritesh, I believe I'll take your first question first. Our unit economics are still structured so that gross margin ought to come in at 42% plus. Naturally, that figure should get better as B2C accounts for a larger share of the total business mix, which is what we intend as well, and we've been working toward that too. That said -- and once February came around, it began, and we tried to hold that line as well. But as I said earlier -- in response to the previous question -- it comes down to a trade-off. We could keep raising prices without regard for volume, and we could lift prices without limit and hold our margins, yet that would damage the overall volumes we'd have. So a balance always has to be struck between the two. If this had been something permanent, we would have pressed ahead and locked it in. But given that it's something temporary, it makes no sense to give up business for a brief stretch and then forfeit the growth we could have captured from it. On elasticity, I'd say elasticity is quite high, and we tested that during the current quarter.
We had never raised prices to this degree. Our habit was to stay careful, since any hike could trigger a market response, and that could hurt us. This time, though, we went full force and raised prices not just once but several times, because raw material costs kept climbing INR 10, INR 20 every 15 days. That experiment has worked quite well. We think it has also given us the confidence to push our margins higher and stop worrying so much about losing business or similar concerns. If the present situation is abnormal, a 50% increase in raw material prices becomes, to some degree, unaffordable as well, particularly for the consumer. So I don't think -- I think, yes, we have given up a little on margins. Maybe with 15% growth, we should have earned INR 15 crores to INR 20 crores more of EBITDA. But I believe that in business, the right thing is to move past these temporary phenomena and then seek to work from a position of strength and build up both business volumes and profitability. As far as volumes go, and we have witnessed this many times in the business, I still recall that 3 years back, our volumes were rising 10% to 15%, yet raw material prices were steadily falling, which meant our top line was nearly flat.
I think there is some kind of connection between what customers can afford and the volumes that stay in the business, and that shows up from time to time. If you looked at a period of 5 years, I think you would find that 2/3 or 3/4 of the growth that would have come -- would come -- have come from volumes and 1/3 or 1/4 would be from value, which I believe should be a normal scenario. But yes, an extreme situation will tilt it toward one side at one point of time and toward the other side at the other point of time.
Just one quick follow-up here, sir. Sir, are you going to share volume growth for the Sleepwell brand? We do give it for e-com and U20. How much would come from outside e-com and U20, say?
Look, Ritesh, our perspective on this is somewhat different. These days, what you're seeing is the era of omnichannel — you create the lead on the internet and afterward complete the sale in a physical location. You bring the customer to the online — offline shops so they can actually touch and feel the product. And in the online space, they go to learn about the products, the various features, what advantages they offer, the different kinds of materials used, and what price points we might expect across different products. Then he might decide to purchase on the internet, or he might visit a brick-and-mortar store and decide to buy there. So I'd say we don't view growth across the 2 channels as separate things. At the end of the day, what sells is the Sleepwell or the Kurlon brand. And so, we'd recommend that we also examine this from the standpoint of the brand as a whole rather than by the channels through which it's sold.
Sir, I want to put this question to you point-blank. What I'm trying to get at is this: how are we approaching the volume mix? The reason is that with the Sleepwell brand, e-com, and U20, the products underneath them are, I believe, different. Since those underlying products differ, the TDI plus polyol cost is going to be quite different across all 3 buckets. That means the way costs rise will look very different for each of the 3 channels. So I just wanted to grasp how the pricing strategy works to pull in better volumes while not giving up ground on gross margins?
Okay Ritesh, let me jump in on that. So here's what's happened with the various price hikes: there's a big chunk of the market sitting below the INR 10,000 price point. Those successive increases have pushed us past that level, and we now find ourselves at roughly INR 11,000 to INR 12,000 plus. So we've recently brought in a technology where we'll produce a support layer that goes into the product, and we intend to position it at under INR 10,000 with a margin comparable to what we earn in the mid-segment. That means no margin dilution, and at the same time we capture the customer base at that price point. That's the plan for winning back volume. We've also been concentrating on premiumization — that's one side of what we're doing. And simultaneously, the sub-INR 10,000 price point market, which in my view even today accounts for nearly 40% of the market, sits right there.
Sir, just one last follow-up question from me.
Apologies for cutting in, Mr. Shah. Kindly get back in the queue if you have further questions. Our next question is from Dikshi Jain of InCred Research.
Let me start with my first question about the festive sales. Last year, Navratri fell in Q2, while this year it landed in Q3. So how has the response been up to now? Have you managed to observe a volume uptick during the festive days that have already passed? That's my first question.
Dikshi, on this call I don't believe we're able to comment on the current quarter. The only quarter we can comment on is the last one.
Even so, the launches reaching the market have clearly accelerated on the whole. What we witnessed in September, certainly in October, and looking ahead, the wedding season — those all appear more favorable.
My next question is about U2O volumes. In this quarter, growth in the U2O segment wasn't very strong, even though U2O's base itself is quite low. So looking ahead, have we added more touch points in Q2 as well? What's the plan going forward to maintain volume momentum in this segment?
Two things on that. First, as I mentioned, U2O raised prices as well. That led us to step away from certain sweet spots around INR 8,000 and INR 9,000. That's the first point. In response, we've deepened our distribution reach — that's one action. And second, we're bringing out a product built on new technology, which should protect our margins and let us re-enter the price point we exited. Those 2 moves ought to restore volume growth for U2O.
What's the overall amount of price increases we've implemented over the past 1.5 years — 1, 1.5 years?
Since the Middle East situation began, we've implemented roughly a 35% to 40% price increase on foam and about 25-odd percent on mattress.
<<operator_script>> Our following question is from Rahul Agarwal of IKIGAI Asset.
I had several questions as well, but I'll keep it to 2. So first, on the festival shift, how should we think about mattress volume growth for the second half, sir? The first half was flat Y-o-Y. For the second half, should we expect double digits? Any sense, any outlook you can give us?
So all of this, Rahul, is going to hinge on <<inaudible>> how things play out. If the situation stays as it is, if you witness additional disruptions in the Middle East plus further hikes in raw material prices, then I think that approach will keep being the one we stick with to safeguard profitability or the margins, which could have some effect on volumes. But if it holds flat or perhaps begins to soften, then yes, what you're describing ought to become a reality.
Okay, and then second, as I look ahead to next year, fiscal '28, if conditions return to normal, the pattern would be that volumes rise, pricing falls, and revenue growth then drops to single digits. Is that the right way to understand it? Or how are you viewing the business for next year?
That's an interesting point, Rahul. What we're seeing right now—that 15% to 18% top line growth—stems largely from price increases. So if prices were to return to the same level, which I don't think will happen, then yes, prices will come down, but they'll settle somewhere in between where they are now and where they stood before February. Should that occur, you're right that part of the growth we've seen would be eroded, while some would come from higher volumes or the extra efforts we undertake. Our intent will remain a 15% growth on a CAGR basis, year over year. And we believe all the initiatives we've put in place ought to be enough to deliver that 15% growth regardless of the environment. So if the environment eases, growth will come through volume; if it doesn't ease, it will come through value.
Understood, sir. And finally, regarding the minority interest — once we consolidate 100% line by line, what percentage for minority interest should we assume gets deducted?
It’ll come down to the equity conversion — somewhere from 35% to 43% would belong to us. So whatever portion is ours, 100% minus 35% or 43%, that becomes the minority interest reduced within other comprehensive income, not <<inaudible>>.
Right. Just to clarify on that quarter, I wanted to confirm it. From an accounting standpoint, how much should we take as minority interest at this point?
My apologies for cutting in, Mr. Rahul. Kindly get back in the queue if you have further questions.
Just a quick follow-up here. I'm not posing any questions.
No, no, please. I'll answer your question. So let's say the equity conversion at that point is 40%, meaning we hold 40% of the converted equity share, then the minority percentage would be 60% of Furlenco's. Does that answer your question?
<<operator_script>> Our following question is from Keshav Garg of Counter Cyclical PMS.
Sir, my first question concerns Furlenco. Sir, I'd like to get a handle on the business model. Is it — is it right to think that Furlenco begins by manufacturing the furniture, then capitalizes it on its books, and after that rents that furniture out? Have I got that right?
Right. So, I believe 5 years ago, they would lease assets and then rent them out. But at this point, because their capital position is pretty solid, they purchase the assets, record them as fixed assets on their books, and then rent them out.
Sir, in that situation EBITDA doesn't really mean much, since the primary cost in our rental business is finance cost. So I mean — and second, when it comes to consolidating Furlenco, where our holding is between 35% and 43% in the best case, why not simply take our share of interest in the associate? And although we do control it, we could just add our share of profits instead of fully consolidating, which in my humble opinion would only distort the picture for the entire entity.
Thanks, Keshav, for sharing your view.
And then, sir, moving on to the second point: of that INR 600 crore EBITDA for this year, how much is expected to come from Furlenco?
So, as I said earlier, and also addressing one of the questions: that INR 600 crores figure is our run rate on a pro forma basis. Furlenco accounts for INR 200 crores, and the remaining INR 400 crores to INR 450 crores will come from us — the existing Sheela Foam consolidated.
Sir, so from that INR 450 crore — INR 400 crore, INR 450 crore.
Apologies for cutting in, Mr. Garg. Kindly get back in the queue if you have further questions. <<operator_script>> Our next question is from Shantanu Basu of SMIFS.
I think just about everything I had has been covered, except for one item. That one is about the debt outlook. So what should we expect for the company's debt outlook in FY '27? And how much do you anticipate paying up? And what would the closing debt figure be for FY '27, and also for FY '28 and beyond?
Yes. So, Shantanu, I'll break that down into two parts. First, at the current consolidated level of Sheela Foam, we have roughly INR 600 crores of net debt as of today. By year-end, we expect that figure to land somewhere in the range of INR 500 crores to INR 550 crores, and I'm talking about consolidated debt here. However, since Furlenco will be consolidated, Furlenco will carry a net debt of INR 250 crores. So the total will come to somewhere around INR 800 crores, with an EBITDA of INR 600 crores.
Alright. Alright. And starting with FY '28, what amount do you anticipate paying?
So out of the consolidated Sheela Foam as it stands, whatever free cash flow we generate — which should land somewhere in the range of INR 150 crores to INR 200-odd crores — that gets applied toward bringing debt down. Furlenco, naturally, consumes all the cash it draws, since we expect it to grow at over 30%. As a result, net debt there won't come down, perhaps a reduction of about INR 50 crores. So you can still count on roughly INR 200 crores of reduction each year.
Resham Jain with VVD Asset Managers has the next question.
I’ve got one question about the total investment in Furlenco and the value that creates. Rahul sir said earlier that there’s another listed company in a comparable space. So with Furlenco set to be a 43% subsidiary and with substantial minority interest in that company, how would you create value for shareholders through it? Are you thinking about any timeline for that?
Thank you, Resham. The very first thing we needed to do was turn Furlenco around. A listing might also be proposed for next year, though that too follows from the private equity holders who are there and hold a right to go public so they have an exit route. Other than that, a listing wasn't needed either. So I understand where you're coming from regarding how the value created in Furlenco will ultimately benefit the investors. This is a somewhat complex topic. We have begun thinking about it. And perhaps at some point, we'll be able to tell you how we expect to deliver it. To be honest, until now we were only focused on creating value in the company.
Then the second piece is also tied to Furlenco, but it concerns the synergies available in the core Sheela Foam and Kurlon business on the furniture side, since I noticed in your press release that you intend to move into furniture within the core brand business too. If you could walk us through what the strategy there will be, that would be helpful as well.
Absolutely. Absolutely, Resham. So bringing Furlenco into the fold gives us a distinct edge. Even though it's a furniture rental business, it still holds the full value chain — furniture design, furniture manufacturing, logistics oversight for suppliers, and managing consumers within that segment. Furlenco manufactures a portion of its furniture itself, yet the bulk of it gets produced through outsourced arrangements. Now that Furlenco is with us, we're leveraging them as our back end. They'll handle design work for our furniture. Naturally, a complete marketing and sales team sits here at Sheela Foam, and that team will liaise with them and carry out marketing plus sales for those products. However, when it comes to manufacturing — meaning design, production, and logistics support — Furlenco will provide all of it. Both companies stand to gain from this. We won't have to commit substantial CapEx to launch this business, and our growth potential will be unlimited should the market back us. Simultaneously, it offers Furlenco a solid chance to earn some additional money from the sales it carries out on our behalf.
So that's the approach we've taken. We've already introduced Sleepwell and Kurlon beds and recliners online. And it won't be long before they show up in some of our stores, and from there we'll keep widening that out.
Our following question is from Dikshant Gupta of Geojit PMS.
Can everyone hear me?
Yes, please, go right ahead.
Right, so my question concerns Furlenco. I'd like to find out whether you can share some economics — when you bring in a piece of furniture, what does the payback period typically look like on it? And what kind of IRR do you earn from it?
I can say that, for the company, the return on assets and the return on capital employed are currently around 25%. However, when it comes to payback or IRR, you'll appreciate that this industry is competitive — competition sensitive — and those kinds of KPIs can't be disclosed.
And does Furlenco also make its own furniture? Or does it mostly just buy it from outside?
Could you say that again, please?
My question was whether Furlenco manufactures its own furniture or purchases the majority of it from other players?
Roughly 20% to 30% of their furniture is produced by them, while the remainder is outsourced. Over the last 2, 3 years, if you look at the big investments they've made, those have been in rentable furniture, since capital was constrained and we were the sole providers of capital to them. Naturally, in the future they would raise that ratio, and perhaps a certain percentage of manufacturing would move in-house. Still, outsourcing is going to stay, and it will continue to account for a major share of their manufacturing capability.
With Sheela Foam, along with Kurlon and Furlenco, if more manufacturing gets brought in-house, that could create some synergies, since both would need in-house manufacturing.
Right, but a balance has to be struck, since manufacturing facilities require substantial CapEx. And outsourcing is sound economics too. Actually — once you work out the cost of capital plus the depreciation involved, doing it on volume — with volume — comes out more efficient, I'd say. And second, you're operating in an industry that can hit good times or bad. So you don't want to be flooded with a lot of capacity that could sit vacant during a bad period.
Rishi Mody with Mody Advisory has the next question.
Is this coming through for everyone?
Apologies, your voice isn’t coming through clearly at all.
Yeah, we’re able to hear you.
Yeah. Is that an improvement?
Yes, please go ahead.
Okay, so for the first question, just some quick housekeeping. I noticed that in your cash flow from operations, we received INR 33 crores back as a reversal of a tax payment. I just wanted to ask where that is coming from. And also, once Furlenco is consolidated into our accounts, do we gain any advantage from their accumulated losses to offset the stand-alone profits of Sheela Foam?
We're bringing them together, but they aren't being merged. As a result, no tax benefit will come from their losses. Right — however, they'll keep enjoying the advantages tied to their prior losses. What was the first question you asked?
Looking at your cash flow statement, I notice an amount of INR 33 crores.
Yeah. The tax breakdown.
Regarding benefit.
Right, exactly. There are 13 intangible assets — things like brands, customer contracts, et cetera — that came about following the Kurlon acquisition, and those are tax amortizable. So at the time the 2 companies merged, we created a deferred tax asset, and now those deferred tax assets are being amortized. So this is amortization of a deferred tax asset rather than tax actually paid, which is why you see it showing up as cash in the company. As for the INR 23 crores or INR 33 crores you would have noticed, that stems from the merger taking effect on 20th of October 2023. So for those years, the income tax returns were revised, and that produced a refund of the tax we had paid in those years. So that's the amount sitting there.
And should we expect any additional benefit from this, or does that conclude it, sir?
Yeah. No, I believe the figure comes to roughly INR 150-odd crores. So I think that should carry us through another year or 2 without us having to pay taxes.
Second, I just wanted to ask — so in your opening remarks, Rahul ji, you said that due to the Middle East crisis, some factories making polyol and TDI have been destroyed or damaged. Just to get a sense now of how much capacity has been removed from the market because of this, by when is new capacity expected to arrive, and how much new capacity is expected to arrive? So just to get an idea of how long this polyol, TDI inflation or these levels will stay in play?
Part of this comes down to capacity constraints, though logistics plays an even bigger role. If you look at TDI overall, I'd estimate that roughly 15% to 20% of it has been eliminated — first as a result of the war, and second from European industries shutting down. On the polyol side, the impact is somewhat smaller. Still, as I mentioned, the difficulty lies in logistics rather than in lost capacity, even though certain plants are shutting while others are opening up.
So, when you look at TDI and polyol today, setting aside the logistics delays, would you say absolute demand is running ahead of supply, or how would you describe the situation right now—demand versus supply at absolute levels?
Okay, so if you looked at this from space and added up all the demand and all the capacity, you'd see that capacity is slightly greater than what demand is today. There's also been demand declining around the world. But it's all in the wrong locations. Eventually it has to move, and it has to be made available where the need, the requirement, is. So once everything returns to normal again, and hopefully that happens fast, there would be sufficient supply for the demand unless -- I mean, I don't know. I'm thinking about this at the same time as well.
So once the Hormuz situation is resolved, we should see some relief when it comes to pricing. Is that a fair inference to draw?
Yes.
Ladies and gentlemen, that brings today's session to a close—we've taken our final question, and the Q&A portion is now finished. I'll turn things back over to management for some closing remarks.
Much appreciation to all of you for joining this conference. And as usual, it has been — I mean, we find the questions to be a learning exercise. We really do gain a great deal, and many thanks for that. I would just like to say that I will wrap up by wishing festival greetings to each of you, and may you and your family have a wonderful Diwali. Thank you so much.
I appreciate that.
Thanks.
Thank you. That brings this conference to a close on behalf of Emkay Global Financial Services Limited. We appreciate your participation, and you can go ahead and disconnect your lines at this point.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Sheela Foam Limited transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Sheela Foam Limited earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.